UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 5
May-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2305630


Registration ID:
515333

Page Number

g204-g214

Share This Article


Jetir RMS

Title

A REVIEW ON: “BLOOD CANCER”

Abstract

Blood cancers occur due to abnormal production and the function of your blood cells. Most of these cancers in bone marrow where blood cell is produced. Stem cells in bone marrow mature and develop into three types of blood cells: red blood cells, white blood cells, or platelets. In most blood cancers, the normal blood cell development process is interrupted by the uncontrolled growth of an abnormal type of blood cell. These abnormal blood cells, or cancerous cells, prevent blood cell from performing many of its functions, like fighting off infections or preventing serious bleeding. There are three main groups of blood cancer are leukemia, lymphoma (Hodgkin lymphoma, Non-Hodgkin lymphoma), myeloma, and Myelodysplastic syndromes (MDS). Treatment for blood cancer depends on the type of cancer, age, how fast the cancer is progressing, where cancer has spread and other factors and some common treatments for blood cancers are chemotherapy, radiotherapy and, in some cases, a stem cell or bone marrow transplant.

Key Words

Myelodysplastic syndromes chemotherapy, radiotherapy

Cite This Article

"A REVIEW ON: “BLOOD CANCER”", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 5, page no.g204-g214, May-2023, Available :http://www.jetir.org/papers/JETIR2305630.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A REVIEW ON: “BLOOD CANCER”", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 5, page no. ppg204-g214, May-2023, Available at : http://www.jetir.org/papers/JETIR2305630.pdf

Publication Details

Published Paper ID: JETIR2305630
Registration ID: 515333
Published In: Volume 10 | Issue 5 | Year May-2023
DOI (Digital Object Identifier):
Page No: g204-g214
Country: Ahmednagar, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000465

Print This Page

Current Call For Paper

Jetir RMS